MED12 exon 2 mutations in histopathological uterine leiomyoma variants

MED12 exon 2 mutations are common in uterine leiomyomas from South African patients

(2015) Netta Mäkinen et al.   Oncotarget

Morphologic and Molecular Characteristics of Uterine Leiomyomas in Hereditary Leiomyomatosis and Renal Cancer (HLRCC) Syndrome

(2012) Julian Sanz-Ortega et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer

(2012) K Kämpjärvi et al.   BRITISH JOURNAL OF CANCER

Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors

(2012) Eun Mi Je et al.   INTERNATIONAL JOURNAL OF CANCER

MED12 mutations in uterine fibroids-their relationship to cytogenetic subgroups

(2012) Dominique Nadine Markowski et al.   INTERNATIONAL JOURNAL OF CANCER

Whole Exome Sequencing in a Random Sample of North American Women with Leiomyomas Identifies MED12 Mutations in Majority of Uterine Leiomyomas

(2012) Megan M. McGuire et al.   PLoS One

MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors

(2012) Gaëlle Pérot et al.   PLoS One

Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics

(2011) Heli J. Lehtonen   Familial Cancer

MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas

(2011) N. Makinen et al.   SCIENCE

The human Mediator complex: a versatile, genome-wide regulator of transcription

(2010) Dylan J. Taatjes   TRENDS IN BIOCHEMICAL SCIENCES

Association of Germline Mutations in the Fumarate Hydratase Gene and Uterine Fibroids in Women With Hereditary Leiomyomatosis and Renal Cell Cancer

(2008) Laveta Stewart et al.   ARCHIVES OF DERMATOLOGY

The Human CDK8 Subcomplex Is a Histone Kinase That Requires Med12 for Activity and Can Function Independently of Mediator

(2008) M. T. Knuesel et al.   MOLECULAR AND CELLULAR BIOLOGY